Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Enterprise Financing Schemes
This key economic indicator for the Healthcare sector has been recently updated.
- In 2019, Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Enterprise Financing Schemes in Switzerland jumped by 33.3% from a year earlier.
- Since 2014 Germany Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Enterprise Financing Schemes increased 3.2% year on year totalising €1.09 Per Capita.
- In 2019 Switzerland was ranked number 2 in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Enterprise Financing Schemes.
Top Countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Enterprise Financing Schemes
# | 2 Countries | Euros Per Capita | Last | YoY | 5‑years CAGR | |
---|---|---|---|---|---|---|
1 |
#1
Germany
|
1.09 | 2019 | +2.8 % | +3.2 % | View data |
2 |
#2
Switzerland
|
0.04 | 2019 | +33.3 % | -27.5 % | View data |
Source: European Commission